Guoliang Cao

1.3k total citations
32 papers, 1.0k citations indexed

About

Guoliang Cao is a scholar working on Molecular Biology, Psychiatry and Mental health and Electrical and Electronic Engineering. According to data from OpenAlex, Guoliang Cao has authored 32 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 5 papers in Psychiatry and Mental health and 5 papers in Electrical and Electronic Engineering. Recurrent topics in Guoliang Cao's work include HIV/AIDS drug development and treatment (3 papers), HIV Research and Treatment (3 papers) and Advancements in Battery Materials (3 papers). Guoliang Cao is often cited by papers focused on HIV/AIDS drug development and treatment (3 papers), HIV Research and Treatment (3 papers) and Advancements in Battery Materials (3 papers). Guoliang Cao collaborates with scholars based in United States, China and United Kingdom. Guoliang Cao's co-authors include G. Richard Granneman, John M. Leonard, Ann Hsu, Eugene Sun, Jorge E. Toblli, Keith Erdman, Margarita Angerosa, Sandeep Dutta, Paolo Baroldi and Emil Samara and has published in prestigious journals such as Journal of Power Sources, Antimicrobial Agents and Chemotherapy and International Journal of Hydrogen Energy.

In The Last Decade

Guoliang Cao

31 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Guoliang Cao United States 17 248 208 177 172 131 32 1.0k
Isabelle Madelaine France 19 110 0.4× 534 2.6× 331 1.9× 75 0.4× 44 0.3× 73 1.2k
Dirk Lebrecht Germany 21 289 1.2× 217 1.0× 388 2.2× 211 1.2× 12 0.1× 32 1.4k
Masaki Kawamura Japan 24 47 0.2× 98 0.5× 465 2.6× 72 0.4× 26 0.2× 113 2.0k
Thomas Papoian United States 14 133 0.5× 108 0.5× 428 2.4× 71 0.4× 12 0.1× 20 954
J. H. Beijnen Netherlands 17 100 0.4× 295 1.4× 320 1.8× 73 0.4× 16 0.1× 40 797
Lauriane Goldwirt France 19 204 0.8× 216 1.0× 259 1.5× 71 0.4× 9 0.1× 53 1.1k
Tot Bui United States 15 199 0.8× 328 1.6× 174 1.0× 164 1.0× 3 0.0× 30 749
Dominique Ducint France 14 52 0.2× 176 0.8× 250 1.4× 19 0.1× 26 0.2× 29 1.2k
Xinglin Wu United States 10 155 0.6× 259 1.2× 406 2.3× 116 0.7× 10 0.1× 25 957
Bin Xu China 22 96 0.4× 613 2.9× 728 4.1× 47 0.3× 11 0.1× 97 1.9k

Countries citing papers authored by Guoliang Cao

Since Specialization
Citations

This map shows the geographic impact of Guoliang Cao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guoliang Cao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guoliang Cao more than expected).

Fields of papers citing papers by Guoliang Cao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guoliang Cao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guoliang Cao. The network helps show where Guoliang Cao may publish in the future.

Co-authorship network of co-authors of Guoliang Cao

This figure shows the co-authorship network connecting the top 25 collaborators of Guoliang Cao. A scholar is included among the top collaborators of Guoliang Cao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guoliang Cao. Guoliang Cao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Mingjie, Guoping Ding, Huilian Huang, et al.. (2020). Interferon gamma inhibits CXCL8–CXCR2 axis mediated tumor-associated macrophages tumor trafficking and enhances anti-PD1 efficacy in pancreatic cancer. Journal for ImmunoTherapy of Cancer. 8(1). e000308–e000308. 136 indexed citations
2.
Wang, Yan, et al.. (2019). The inhibitory role of recombinant P‑selectin glycoprotein ligand immunoglobulin G on portal vein thrombosis based on a novel rat model. Experimental and Therapeutic Medicine. 17(5). 3589–3597. 3 indexed citations
3.
Chen, Xuedong, et al.. (2018). P-Selectin Level at First and Third Day After Portal Hypertensive Splenectomy for Early Prediction of Portal Vein Thrombosis in Patients With Cirrhosis. Clinical and Applied Thrombosis/Hemostasis. 24(9_suppl). 76S–83S. 12 indexed citations
4.
Velletri, Tania, Ying Wang, Yin Huang, et al.. (2016). P53 functional abnormality in mesenchymal stem cells promotes osteosarcoma development. Cell Death and Disease. 7(1). e2015–e2015. 78 indexed citations
5.
Li, Xiaoli & Guoliang Cao. (2015). [Potential role of microRNA-181b on atherosclerosis].. PubMed. 43(6). 516–20. 3 indexed citations
6.
Toblli, Jorge E., et al.. (2010). Comparison of the renal, cardiovascular and hepatic toxicity data of original intravenous iron compounds. Nephrology Dialysis Transplantation. 25(11). 3631–3640. 59 indexed citations
7.
Toblli, Jorge E., Mónica G. Ferrini, Guoliang Cao, et al.. (2009). Antifibrotic effects of pioglitazone on the kidney in a rat model of type 2 diabetes mellitus. Nephrology Dialysis Transplantation. 24(8). 2384–2391. 57 indexed citations
8.
He, Jun, Hirofumi Nishida, Lingxin Chen, et al.. (2008). Inactivation Mechanism of Microorganisms by the Synergy of Silver and Light Irradiation, and the Application in Household Electrical Appliances. Chinese journal of biotechnology/Shengwu gongcheng xuebao. 24(6). 1091–1097. 2 indexed citations
9.
Toblli, Jorge E., Daniel Grana, Guoliang Cao, & José Milei. (2007). Effects of ACE Inhibition and β-Blockade on Plasminogen Activator Inhibitor-1 and Transforming Growth Factor-β1 in Carotid Glomus and Autonomic Ganglia in Hypertensive Rats. American Journal of Hypertension. 20(3). 326–334. 4 indexed citations
10.
Cao, Guoliang, et al.. (2006). In Vivo and in Vitro Effects of Nebivolol on Penile Structures in Hypertensive Rats. American Journal of Hypertension. 19(12). 1226–1232. 22 indexed citations
11.
Xie, Jian, X ZHAO, Guoliang Cao, Meiping Zhao, & S. Su. (2004). Solvothermal synthesis and electrochemical performances of nanosized CoSb as anode materials for Li-ion batteries. Journal of Power Sources. 140(2). 350–354. 35 indexed citations
12.
Cloyd, James C., et al.. (2003). Valproate unbound fraction and distribution volume following rapid infusions in patients with epilepsy. Epilepsy Research. 53(1-2). 19–27. 52 indexed citations
13.
Samara, Emil, Sandeep Dutta, Guoliang Cao, et al.. (2001). Single‐Dose Pharmacokinetics of Atrasentan, an Endothelin‐A Receptor Antagonist. The Journal of Clinical Pharmacology. 41(4). 397–403. 21 indexed citations
14.
Hsu, Ann, G. Richard Granneman, Guoliang Cao, et al.. (1998). Pharmacokinetic Interaction between Ritonavir and Indinavir in Healthy Volunteers. Antimicrobial Agents and Chemotherapy. 42(11). 2784–2791. 130 indexed citations
15.
Hsu, Ann, G. Richard Granneman, Guoliang Cao, et al.. (1998). Pharmacokinetic interactions between two human immunodeficiency virus protease inhibitors, ritonavir and saquinavir*. Clinical Pharmacology & Therapeutics. 63(4). 453–464. 135 indexed citations
16.
Gustavson, Linda E., Allen Cato, Samuel W. Boellner, et al.. (1998). Lack of Pharmacokinetic Drug Interactions Between Tiagabine and Carbamazepine or Phenytoin. American Journal of Therapeutics. 5(1). 9–16. 13 indexed citations
17.
Awni, Walid M., John H. Cavanaugh, Philip T. Leese, et al.. (1997). The pharmacokinetic and pharmacodynamic interaction between zileuton and terfenadine. European Journal of Clinical Pharmacology. 52(1). 49–54. 15 indexed citations
18.
Wong, Shekman, et al.. (1997). The Effect of Erythromycin on the CYP3A Component of Sertindole Clearance in Healthy Volunteers. The Journal of Clinical Pharmacology. 37(11). 1056–1061. 12 indexed citations
19.
Samara, Emil, et al.. (1997). Population analysis of the pharmacokinetics and pharmacodynamics of seratrodast in patients with mild to moderate asthma*. Clinical Pharmacology & Therapeutics. 62(4). 426–435. 15 indexed citations
20.
Wong, Shekman, Guoliang Cao, Randall J. Mack, & G. Richard Granneman. (1997). Pharmacokinetics of sertindole in healthy young and elderly male and female subjects*. Clinical Pharmacology & Therapeutics. 62(2). 157–164. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Isabelle Madelaine Breakdown of academic impact, for papers by Dirk Lebrecht Breakdown of academic impact, for papers by Masaki Kawamura Breakdown of academic impact, for papers by Thomas Papoian Breakdown of academic impact, for papers by J. H. Beijnen Breakdown of academic impact, for papers by Lauriane Goldwirt Breakdown of academic impact, for papers by Tot Bui Breakdown of academic impact, for papers by Dominique Ducint Breakdown of academic impact, for papers by Xinglin Wu Breakdown of academic impact, for papers by Bin Xu
Rankless by CCL
2026